Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL3703327

Cn1cc(CCCN)c2cc(F)ccc21.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 1/20 0.43
HTR1D known ✓ P28221 1/20 0.43
HTR2A known ✓ P28223 1/20 0.40
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
ICMT O60725 2/20 0.42
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SNCA P37840 1/20 0.41
SPR P35270 1/20 0.40
MPO P05164 1/20 0.40
HASPIN Q8TF76 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NQO2 P16083 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5241306 0.88 ADRB2 (0.54) LMNATP53RXFP1ADRB2HTR1D
Cadaverine Tartrate SCHEMBL3697458 0.86 LMNA (0.46) LMNATP53RXFP1ADRB2ICMT
SCHEMBL5239371 0.84 ADRB2 (0.52) LMNATP53RXFP1ADRB2HTR1D
SCHEMBL7828706 0.80 LMNA (0.56) LMNATP53RXFP1ICMTKDM4E
SCHEMBL5923660 0.79 ADRB2 (0.64) LMNATP53RXFP1ADRB2HTR1D
Hydrochloric Acid SCHEMBL16592500 0.78 ADRB2 (0.62) LMNATP53RXFP1ADRB2HTR1D
SCHEMBL7734844 0.77 KDM4E (0.51) LMNATP53RXFP1ADRB2HTR1D
SCHEMBL21266309 0.77 ALDH1A1 (0.48) LMNATP53RXFP1ICMTKDM4E
SCHEMBL7734107 0.76 ICMT (0.50) LMNATP53RXFP1ADRB2HTR1D
SCHEMBL7723955 0.74 KDM4E (0.48) LMNATP53RXFP1ADRB2HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122948-A1 3-ALKYL-5-FLUOROINDOLE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS UNIVERSITE LIBRE DE BEUXELLES (BE) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122948-A1 3-ALKYL-5-FLUOROINDOLE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS MPO, SERPINB1, MAOA ADRB2 450/4885HTR1D 177/4885HTR2A 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.